General Disclaimer

OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, you should consult your health care provider.

Related News

Inform Dual ISH test determines if breast cancer patients are candidates for trastuzumab

Jun 16, 2011

Inform Dual ISH test determines if breast cancer patients are candidates for trastuzumab


A total of 64 percent of global asbestos use attributable to Asia from years 2001 to 2007

Jun 24, 2011

A total of 64 percent of global asbestos use attributable to Asia from years 2001 to 2007


Substantial decreases in overall U.S. cancer rates between 1990 and 2007

Jun 20, 2011

Substantial decreases in overall U.S. cancer rates between 1990 and 2007


Frequently Asked Questions

From the National Cancer Institute